Exact Mass: 334.127

Exact Mass Matches: 334.127

Found 29 metabolites which its exact mass value is equals to given mass value 334.127, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Mitomycin

[(4S,6S,7R,8S)-11-amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.0²,⁷.0⁴,⁶]trideca-1(9),11-dien-8-yl]methyl carbamate

C15H18N4O5 (334.1277)


Mitomycin is only found in individuals that have used or taken this drug. It is an antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional alkylating agents causing cross-linking of DNA and inhibition of DNA synthesis. [PubChem]Mitomycin is activated in vivo to a bifunctional and trifunctional alkylating agent. Binding to DNA leads to cross-linking and inhibition of DNA synthesis and function. Mitomycin is cell cycle phase-nonspecific. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D003432 - Cross-Linking Reagents C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents > D000903 - Antibiotics, Antineoplastic > D008937 - Mitomycins D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors D009676 - Noxae > D000477 - Alkylating Agents

   

2,3-Dimercapto-1-propanol tributyrate

2,3-Dimercapto-1-propanol tributyric acid

C15H26O4S2 (334.1272)


   
   

Me glycoside,2,4,6-tri-Ac-3-O-Methylgalactose

Me glycoside,2,4,6-tri-Ac-3-O-Methylgalactose

C14H22O9 (334.1264)


   
   

2,6-dimethoxy-p-hydroquinone 1-O-beta-D-glucoside|2,6-dimethoxyhydroquinone 1-O-beta-D-glucoside

2,6-dimethoxy-p-hydroquinone 1-O-beta-D-glucoside|2,6-dimethoxyhydroquinone 1-O-beta-D-glucoside

C14H22O9 (334.1264)


   

(2s,3R,4S)-3,4-Dihydro-2-methyl-2H-pyran-3,4-diol

(2s,3R,4S)-3,4-Dihydro-2-methyl-2H-pyran-3,4-diol

C14H22O9 (334.1264)


   
   
   

2-acetamido-4,6-o-benzylidene-2-deoxy-beta-d-glucopyranosyl azide

2-acetamido-4,6-o-benzylidene-2-deoxy-beta-d-glucopyranosyl azide

C15H18N4O5 (334.1277)


   

1-[2-(2,4-DiMethylphenylsulfanyl)phenyl]piperazine Hydrochloride

1-[2-(2,4-DiMethylphenylsulfanyl)phenyl]piperazine Hydrochloride

C18H23ClN2S (334.127)


   

1,7-Divinyl-1,1,3,3,5,5,7,7-Octamethyl Tetrasiloxane

1,7-Divinyl-1,1,3,3,5,5,7,7-Octamethyl Tetrasiloxane

C12H30O3Si4 (334.1272)


   

1-[2-(4-Ethoxy-3-fluoropyridin-2-YL)ethyl]-3-(5-methylpyridin-2-YL)thiourea

1-[2-(4-Ethoxy-3-fluoropyridin-2-YL)ethyl]-3-(5-methylpyridin-2-YL)thiourea

C16H19FN4OS (334.1264)


   

[(6R,7S,8R)-11-Amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl carbamate

[(6R,7S,8R)-11-Amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl carbamate

C15H18N4O5 (334.1277)


   

[(4S,6S,7S,8S)-11-Amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl carbamate

[(4S,6S,7S,8S)-11-Amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl carbamate

C15H18N4O5 (334.1277)


   

beta-(N(pros)-L-histidino)-L-tyrosine

beta-(N(pros)-L-histidino)-L-tyrosine

C15H18N4O5 (334.1277)


An L-tyrosine in which one of the beta-hydrogens in L-tyrosine is replaced by a L-histidino group joined via the N(pros)-position.

   

[(4S,6S,7R)-11-amino-13-hydroxy-7-methoxy-12-methyl-10-oxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(13),8,11-trien-8-yl]methyl carbamate

[(4S,6S,7R)-11-amino-13-hydroxy-7-methoxy-12-methyl-10-oxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(13),8,11-trien-8-yl]methyl carbamate

C15H18N4O5 (334.1277)


   

Mitomycin

Mitomycin C

C15H18N4O5 (334.1277)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D003432 - Cross-Linking Reagents C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents > D000903 - Antibiotics, Antineoplastic > D008937 - Mitomycins D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors D009676 - Noxae > D000477 - Alkylating Agents

   
   
   

(2s,3r,4s,5s,6r)-2-{[(1s,6r)-4-hydroxy-2,6-dimethoxycyclohexa-2,4-dien-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(1s,6r)-4-hydroxy-2,6-dimethoxycyclohexa-2,4-dien-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C14H22O9 (334.1264)


   

4,5-dihydroxy-4-(2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)cyclohex-2-en-1-one

4,5-dihydroxy-4-(2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)cyclohex-2-en-1-one

C14H22O9 (334.1264)


   

(2s,3r,4s,5s,6r)-2-{[(1s,4ar,5r,7s,7ar)-5,7-dihydroxy-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(1s,4ar,5r,7s,7ar)-5,7-dihydroxy-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C14H22O9 (334.1264)


   

[(4s,6s,7r,8s)-11-amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.0²,⁷.0⁴,⁶]trideca-1(9),11-dien-8-yl]methoxycarboximidic acid

[(4s,6s,7r,8s)-11-amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.0²,⁷.0⁴,⁶]trideca-1(9),11-dien-8-yl]methoxycarboximidic acid

C15H18N4O5 (334.1277)


   

(4s,5s)-4,5-dihydroxy-4-(2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)cyclohex-2-en-1-one

(4s,5s)-4,5-dihydroxy-4-(2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)cyclohex-2-en-1-one

C14H22O9 (334.1264)


   

(2s,3r,4s,5s,6r)-2-{[(1s,4ar,5r,7s,7as)-5,7-dihydroxy-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(1s,4ar,5r,7s,7as)-5,7-dihydroxy-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C14H22O9 (334.1264)


   

(2r,3s,5s)-2-{[(1s,5r,7s)-5,7-dihydroxy-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3s,5s)-2-{[(1s,5r,7s)-5,7-dihydroxy-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C14H22O9 (334.1264)


   

2-({5,7-dihydroxy-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-1-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

2-({5,7-dihydroxy-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-1-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C14H22O9 (334.1264)